SCHEMBL1491295

SCHEMBL1491295

Oc1ccc2c(c1)n[c]n2O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.41
FGFR1 P11362 1/20 0.39
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
RAD51 Q06609 2/20 0.35
ESR1 P03372 4/20 0.33
ESR2 Q92731 4/20 0.33
MEN1 O00255 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
KMT2A Q03164 1/20 0.33
PRKACA P17612 1/20 0.33
GSK3B P49841 1/20 0.33
ROCK1 Q13464 1/20 0.33
RPS6KA5 O75582 1/20 0.33
CYP3A4 P08684 1/20 0.32
AURKA O14965 1/20 0.31
TNKS O95271 1/20 0.31
PARP1 P09874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1491376 0.84 ENPP2 (0.41) ENPP2FGFR1ALDH1A1KDM4EHPGD
SCHEMBL7818433 0.78 FGFR1 (0.38) ENPP2FGFR1ALDH1A1KDM4EHPGD
SCHEMBL16863946 0.69 PKM (0.58) ENPP2FGFR1ALDH1A1KDM4EHPGD
SCHEMBL7815237 0.67 ESR1 (0.37) ENPP2ALDH1A1KDM4EHPGDESR1
SCHEMBL17265930 0.65 FGFR1 (0.56) ENPP2FGFR1ALDH1A1KDM4EHPGD
SCHEMBL7375589 0.65 ENPP2 (0.42) ENPP2ALDH1A1KDM4EHPGDESR1
SCHEMBL29913593 0.61 POLB (0.55) ENPP2ALDH1A1KDM4EHPGDMEN1
SCHEMBL3125096 0.61 CA2 (0.39) ENPP2FGFR1ALDH1A1KDM4EHPGD
SCHEMBL27919360 0.61 POLB (0.55) ENPP2ALDH1A1KDM4EHPGDMEN1
SCHEMBL1496402 0.60 FGFR1 (0.54) FGFR1ALDH1A1KDM4EHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011029832-A1 NOVEL THIAZOL AND OXAZOL HEPCIDINE ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2011-03-17 WO disclosed